Loading company…
NewBridge Pharmaceuticals commercializes licensed therapies from global pharmaceutical companies in the MENA region.
Based in Dubai, NewBridge Pharmaceuticals licenses therapies from global pharmaceutical companies and supports their commercialization and distribution in the MENA region. Its markets include Saudi Arabia, Egypt, Lebanon, and Morocco. The company raised USD 12.00 mn in a Series B round on September 20, 2010, led by Burrill & Company and National Technology Enterprises Company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in